![]() Gilead Sciences Gilead Sciences is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of medicines. | ![]() Novartis Novartis is a company that researches, develops, manufactures, and markets healthcare products. | ![]() Genfit GENFIT is a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions to address high unmet patient needs. | |
Founding Date | Founding Date 1987 | Founding Date 1996 | Founding Date 1999 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Foster City, US HQ Buenos Aires, AR Melbourne, AU Wien, AT Machelen, BE São Paulo, BR Edmonton, CA see more | Locations Basel, CH HQ Tirana, AL Buenos Aires, AR Macquarie Park, AU Kundl, AT Unterlangkampfen, AT Wien, AT see more | Locations Loos, FR HQ Cambridge, US |
Employees | Employees 18,0006% increase | Employees 75,883 | Employees 180 |
Valuation ($) | Valuation ($) 110.5 b | Valuation ($) N/A | Valuation ($) 280.8 m |
Financial | |||
Revenue (est.) | Revenue (est.) $29.4b (FY, 2025) | Revenue (est.) $56.7b (FY, 2025) | Revenue (est.) €65.4m (FY, 2025) |
Cost of goods | Cost of goods $6.2b (FY, 2025) | Cost of goods $8.4b (FY, 2025) | Cost of goods €302k (FY, 2025) |
Gross profit | Gross profit $23.2b (FY, 2025) | Gross profit $49.8b (FY, 2025) | Gross profit €70.8m (FY, 2025) |
Net income | Net income $8.5b (FY, 2025) | Net income $14b (FY, 2025) | Net income (€86m) (FY, 2025) |
Operating ⚠ | |||
Phase III Trials Products | Phase III Trials Products 9 (FY, 2021) | Phase III Trials Products 44 (FY, 2022) | Phase III Trials Products N/A |
Phase III Trials Products (Oncology) | Phase III Trials Products (Oncology) 4 (FY, 2021) | Phase III Trials Products (Oncology) 27 (FY, 2021) | Phase III Trials Products (Oncology) N/A |

Novartis is a company that researches, develops, manufactures, and markets healthcare products.
View company
GENFIT is a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions to address high unmet patient needs.
View company